© PEGUS Research, Inc. 2016. Salt Lake City, Utah, United States. Tous droits réservés / All rights reserved.
We have been trusted experts in the Rx-to-OTC switch process for 25 years.
Our clients view us as a highly engaged, knowledgeable, and hardworking business partner – not JUST a CRO.
Our educated, accomplished, and professional staff is dedicated to creating customized programs, and their success has led to the continued growth of PEGUS. It will be difficult to find a firm that has conducted more label comprehension, self-selection, and actual use studies over the last several years than we have. In fact, we are the only firm that has supported and conducted research studies on the last two successful Rx-to-OTC switches.
On more than one occasion, PEGUS has been contracted after original program initiation to remediate problems and assemble a network of trained, experienced pharmacy research sites in cases where earlier efforts to create a site network did not fully succeed. We are committed to providing extraordinary service that delivers more value than any competitor.
We develop innovative solutions to complex research problems. Learn more . . .
PEGUS has created a culture of strong leadership, innovation, and agility. We love to generate new ideas and discover unique solutions to our clients’ complex research projects.
We initiated the concept of using pharmacies as enrollment sites and pharmacists as principal investigators for self-selection and actual use studies. Over the years, we have created an extensive network of trained, experienced pharmacy sites and principal investigators for data collection and clinical studies.
We were the first firm to conduct an actual use trial in the United Kingdom in support of the success Rx-to-OTC switch of a medication.
The security, availability, processing integrity, confidentiality, and privacy of your information is important to us. Learn more . . .
PEGUS has recently undergone a SSAE 16 SOC 2 Type I Audit. You can take comfort in knowing that we have controls designed to:
• Protect against unauthorized access
• Keep our system available for operation and use as committed or agreed
• Ensure system processing complete, accurate, timely, and authorized
• Protect information designated as confidential
• Safeguard personal information to make sure it is collected, used, retained, disclosed, and destroyed in conformity with the commitments in the entity’s privacy notice and with criteria set forth in generally accepted privacy principles issued by the AICPA and CICA
Contact Us to learn more